Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00314405
NA

Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope

Sponsor: University Hospital, Strasbourg, France

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the performance of a double labelling method using isotope and methylene blue dye injection to localize precisely Sentinel Lymph Node (SLN) in a series of 100 patients with infiltrative breast cancer justifying SLN excision. Method and patients: SLN excision will be performed on 100 patients treated for infiltrative breast cancer. After preoperative methylene blue dye injection and lymphoscintigraphy, individual localization of the radioactive and stained nodes will be performed. After the surgery, SLN will be submitted to serial analysis and immunohistochemistry. A comparison of the two methods and an economical evaluation of the complete procedure will be performed.

Official title: Identification of Sentinel Lymph Node (SLN) in Breast Cancer Care: Clinical and Economical Evaluation of a Double Method Using Isotope and Methylene Blue Dye Injection.

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2006-04

Completion Date

2008-04

Last Updated

2026-06-08

Healthy Volunteers

No

Interventions

DRUG

Methylene blue (1%)

DRUG

Rhenium sulfure

PROCEDURE

Surgical procedure

PROCEDURE

Anatomo-pathologic procedure

Locations (1)

Service de Gynécologie-Obstétrique, Hôpital Civil

Strasbourg, France